Importantly, the inhibition (Xu et al., 2014) or genetic knockdown (Zhang et al., 2011) of STEP61 ameliorates the behavioral and cognitive impairments seen in AD mouse models, implicating STEP61 as a downstream target of Aβ and mGluR5. This evidence concerns the gene GRM5 and Alzheimer disease.